These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 25773876)
1. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting. Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876 [TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671 [TBL] [Abstract][Full Text] [Related]
3. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934 [TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681 [TBL] [Abstract][Full Text] [Related]
5. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients. Zhang Y; Liu Y; Qiu X; Yan B Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263 [No Abstract] [Full Text] [Related]
6. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma. Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745 [TBL] [Abstract][Full Text] [Related]
7. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases. Neofytou K; Giakoustidis A; Mudan S J BUON; 2015; 20(3):746-55. PubMed ID: 26214626 [TBL] [Abstract][Full Text] [Related]
8. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934 [TBL] [Abstract][Full Text] [Related]
9. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis. Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553 [TBL] [Abstract][Full Text] [Related]
10. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy. Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001 [TBL] [Abstract][Full Text] [Related]
11. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors. Zeman M; Maciejewski A; Półtorak S; Kryj M Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415 [TBL] [Abstract][Full Text] [Related]
13. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor. Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270 [TBL] [Abstract][Full Text] [Related]
14. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer. Shin JS; Suh KW; Oh SY J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893 [TBL] [Abstract][Full Text] [Related]
15. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer. Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer]. Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797 [TBL] [Abstract][Full Text] [Related]
18. Determinants of survival after liver resection for metastatic colorectal carcinoma. Parau A; Todor N; Vlad L J BUON; 2015; 20(1):68-77. PubMed ID: 25778299 [TBL] [Abstract][Full Text] [Related]
19. Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer. Ozawa T; Ishihara S; Kawai K; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T J Surg Res; 2015 Dec; 199(2):386-92. PubMed ID: 26163330 [TBL] [Abstract][Full Text] [Related]
20. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]